ADVERTISEMENT

Home|Journals|Articles by Year|Audio Abstracts
 

Original Article

AJVS. 2026; 89(0): 63-69


Evaluating the Impact of Phytosome Ginger on Histological Section of Sciatic Nerve Dysfunction caused by Alloxan Induced Diabetes in Male Rats

Abother K. Sahib, Buthaina A. Abdullah.



Abstract
Download PDF Post

This study aimed to evaluate the neuroprotective effects of the systematically used ginger and the mechanism of action on alloxan invoked diabetic neuropathy with specific focus on management of painful diabetic neuropathy (PDN). Thirty adult male rats (200 to 250 g) were randomly divided into six groups; control, alloxan (100 mg/kg), ginger extract, phytosome ginger, phytosome ginger with glibenclamide, and ginger extract with glibenclamide. All treatments were administered orally for one month. Histopathological examination of the sciatic nerve showed that alloxan caused intensive neuropathic injury characterized by axonal degeneracy, breaks of myelin sheath, endoneurial thickening, vascular congestion, and inflammatory cell infiltration. Ginger extract partially reduced these changes, whereas phytosome ginger showed higher bioactivity in terms of enhanced nerve fiber organization and reduced Schwann cell and inflammatory.responses.

Key words: Alloxan, Diabetes, Ginger, Glibenclamide, Phytosome, Rats







Bibliomed Article Statistics

19
20
6
R
E
A
D
S

29

14

1
D
O
W
N
L
O
A
D
S
040506
2026

Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Author Tools
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.